Association of GCKR and MBOAT7 genetic
polymorphisms with non-alcoholic fatty liver disease

Association of GCKR and MBOAT7 genetic polymorphisms with non-alcoholic fatty liver disease

Saved in:

Bibliographic Details
Main Authors:	Swati U. Chavan, Pravin Rathi, Ameet Mandot
Format:	Article
Language:	English
Published:	Termedia Publishing House 2024-03-01
Series:	Clinical & Experimental Hepatology
Subjects:	snp nash metabolic syndrome chronic liver disease
Online Access:	https://www.termedia.pl/Association-of-GCKR-and-MBOAT7-genetic-r-npolymorphisms-with-non-alcoholic-fatty-liver-disease,80,52648,1,1.html
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Validation of the Chronic Liver Disease Questionnaire for MASH (CLDQ-MASH)
by: Zobair M. Younossi, et al.
Published: (2025-03-01)

Association of Breastfeeding with Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis in mothers: A cross sectional survey
by: Muhammad Zafar Majeed Babar, et al.
Published: (2024-06-01)

The N‐terminal domain of gasdermin D induces liver fibrosis by reprogrammed lipid metabolism
by: Xue Wang, et al.
Published: (2025-01-01)

Two faces of the same coin non alcoholic fatty liver disease; with and without diabetes: Comparative clinico pathological analysis: A cross sectional observational study
by: Syed Mushfiq, et al.
Published: (2025-01-01)

Marine natural products as an important source of bioactive substances for non-alcoholic fatty liver disease management
by: Menglei Shi, et al.
Published: (2025-01-01)

Prevalence of non-alcoholic fatty liver disease in out-patients of the Russian Federation: DIREG 2 study results
by: V. T. Ivashkin, et al.
Published: (2015-12-01)

Liver and Nutrition. An Optimal Diet for Non-Alcoholic Fatty Liver Disease
by: M. V. Mayevskaya, et al.
Published: (2018-11-01)

The correlation between miR-21 single nucleotide polymorphisms and the susceptibility of non-small cell lung cancer
by: Miao Zhang, et al.
Published: (2025-01-01)

Non-Alcoholic Fatty Liver Disease in Cardiac Patients with Overweight and Obesity
by: I. V. Logacheva, et al.
Published: (2019-01-01)

Epidemiologic features of non-alcoholic fatty liver disease in Russia
by: O. M. Drapkina, et al.
Published: (2014-10-01)

The Safety and Efficacy of Dietary Epigallocatechin Gallate Supplementation for the Management of Obesity and Non-Alcoholic Fatty Liver Disease: Recent Updates
by: Ruike Yan, et al.
Published: (2025-01-01)

Global research trends in Chinese medicine for the treatment of non-alcoholic fatty liver disease (NAFLD): A bibliometric study
by: Kangjie li, et al.
Published: (2025-03-01)

THE SNP-MED SYSTEM FOR ANALYSIS OF THE EFFECT OF SINGLE-NUCLEOTIDE POLYMORPHISMS ON THE FUNCTION OF GENES ASSOCIATED WITH SOCIALLY SIGNIFICANT DISEASES
by: N. L. Podkolodnyy, et al.
Published: (2015-01-01)

Association Between Sociodemographic Variables, Healthy Habits, and Stress with Risk Scales for Liver Disease Associated with Metabolic Dysfunction
by: Ángel Arturo López-González, et al.
Published: (2025-01-01)

A New Hope for the Patients of Non‐Alcoholic Steatohepatitis: FDA Gives Green Signal for Resmetirom Use
by: Abdul Haseeb Hasan, et al.
Published: (2025-01-01)

Yogurt-derived Lactobacillus plantarum Q16 alleviated high-fat diet-induced non-alcoholic fatty liver disease in mice
by: Chao Tang, et al.
Published: (2022-09-01)

Metabolic dysfunction-associated fatty liver disease and risk of nephrolithiasis: a sizeable cross-sectional study
by: Shengqi Zheng, et al.
Published: (2025-01-01)

Efficacy and Safety of Bicyclol Treatment for Non-Alcoholic Fatty Liver Disease: Results of a Cohort Study
by: I. Yu. Pirogova, et al.
Published: (2018-09-01)

Metabolic associated steatotic liver disease misses fewer high-risk patients than metabolic associated fatty liver disease
by: Yu-Ming Cheng, et al.
Published: (2024-12-01)

The rationale for the aggressive progression of MASLD in patients with type 2 diabetes
by: Valeria Michelle Fernández-Garibay, et al.
Published: (2025-01-01)

Studies on the Association of GCK and GCKR Polymorphisms with Susceptibility to Gestational Diabetes Mellitus: A Meta-Analysis
by: Hongxia Tu, et al.
Published: (2025-01-01)

Unraveling the Beneficial Role of Resveratrol in Fructose-Induced Non-Alcoholic Steatohepatitis with a Focus on the AMPK/Nrf2 Signaling Axis
by: Soha S. Zakaria, et al.
Published: (2025-01-01)

Prevalence and factors associated with non-alcoholic fatty liver disease among women with polycystic ovary syndrome
by: Maria Elisa Franciscatto, et al.
Published: (2025-01-01)

Propensity Score Matching Analysis for Alcohol‐Related Liver Disease
by: Fangfang Duan, et al.
Published: (2025-01-01)

Association of leptin receptor Gln223Arg genetic polymorphism with obesity and non-alcoholic fatty liver disease
by: A. V. Morozova, et al.
Published: (2014-09-01)

Identification of biomarkers associated with coronary artery disease and non-alcoholic fatty liver disease by bioinformatics analysis and machine learning
by: Chuan Lu, et al.
Published: (2025-01-01)

An Effect of Ursodeoxycholic Acid on Inflammation, Steatosis and Liver Fibrosis and Atherogenesis Factors in Patients with Non-Alcoholic Fatty Liver Disease: Results of the USPEH Study
by: M. V. Mayevskaya, et al.
Published: (2020-01-01)

Improvement of non-alcoholic fatty liver disease treatment
by: P. I. Seliverstov, et al.
Published: (2014-10-01)

Prevalence of non-alcoholic fatty liver disease at obesity and its interrelation with cardio-vascular disease and 2nd type diabetes mellitus risk factors
by: G. A. Melnichenko, et al.
Published: (2012-04-01)

Ethanol extract of Polygonatum cyrtonema Hua mitigates non-alcoholic steatohepatitis in mice
by: Dongliang Chen, et al.
Published: (2025-01-01)

Laboratory diagnostics of alcohol intoxication in patients with alcohol-induced liver disease
by: A. I. Pavlov, et al.
Published: (2010-02-01)

Flanking monomer repeats define lower context complexity of sites containing single nucleotide polymorphisms in the human genome
by: N. S. Safronova, et al.
Published: (2016-01-01)

Burden of NASH related liver cancer from 1990 to 2021 at the global, regional, and national levels
by: Shuang Li, et al.
Published: (2025-01-01)

Lipid spectrum in liver cells and peripheral blood lymphocytes at children with chronic hepatitis B
by: V. G. Bulygin
Published: (2011-05-01)

Profile of Children With Non-alcoholic Fatty Liver Disease Referred to a Hospital in Iran
by: Amin Ghanbari, et al.
Published: (2024-12-01)

Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion
by: V. V. Tsukanov, et al.
Published: (2023-11-01)

Research of <i>PNPLA3</i> I148M Gene Polymorphism in Patients with Non-Alcoholic Fatty Liver Disease, with Liver Cirrhosis and with Hepatocellular Carcinoma
by: V. V. Petkau, et al.
Published: (2023-11-01)

Usefulness of pemafibrate for non-alcoholic fatty liver disease with hypertriglyceridemia
by: Masahiro Kikuchi, et al.
Published: (2024-09-01)

miRNAs and Hematological Markers in Non-Alcoholic Fatty Liver Disease—A New Diagnostic Path?
by: Agata Michalak, et al.
Published: (2025-01-01)

The impact of SLCO1B1 polymorphisms on homocysteine concentrations: evidence for a stronger association in men
by: Xinyuan Hu, et al.
Published: (2025-01-01)